Dicerna Pharmaceuticals, Inc.
Therapeutic inhibition of lactate dehydrogenase and agents therefor

Last updated:

Abstract:

This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Status:
Grant
Type:

Utility

Filling date:

1 Jul 2020

Issue date:

14 Jun 2022